Acrivon Therapeutics, Inc. Common Stock
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACRV research report →
Companywww.acrivon.com
Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates.
- CEO
- Peter Blume-Jensen
- IPO
- 2022
- Employees
- 75
- HQ
- Watertown, MA, US
Price Chart
Valuation
- Market Cap
- $55.54M
- P/E
- -0.88
- P/S
- 0.00
- P/B
- 0.71
- EV/EBITDA
- -0.28
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -64.43%
- ROIC
- -84.09%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-77,905,000 · 3.29%
- EPS
- $-2.02 · 3.81%
- Op Income
- $-84,114,000
- FCF YoY
- 4.53%
Performance & Tape
- 52W High
- $3.56
- 52W Low
- $1.05
- 50D MA
- $1.72
- 200D MA
- $1.83
- Beta
- 2.02
- Avg Volume
- 791.44K
Get TickerSpark's AI analysis on ACRV
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 18, 26 | RA CAPITAL MANAGEMENT, L.P. | other | 9,366 |
| May 18, 26 | TOMSICEK MICHAEL JOHN | other | 9,366 |
| May 18, 26 | Shacham Sharon | other | 9,366 |
| May 18, 26 | Palani Santhosh | other | 9,366 |
| May 18, 26 | Magovcevic-Liebisch Ivana | other | 9,366 |
| May 18, 26 | DiRocco Derek | other | 9,366 |
| May 18, 26 | BAUM CHARLES M | other | 9,366 |
| May 18, 26 | Peterson Katharine | other | 14,227 |
| May 18, 26 | Mirza Mansoor Raza | other | 38,817 |
| May 18, 26 | Miller Mary | other | 49,830 |
Our ACRV Coverage
We haven't published any research on ACRV yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ACRV Report →